Evidence map›Paper›PMID 28341739›Full record

ArticleThe Journal of biological chemistry2017

Modifiers of prion protein biogenesis and recycling identified by a highly parallel endocytosis kinetics assay.

Boris A Ballmer, Rita Moos, Prisca Liberali, Lucas Pelkmans, Simone Hornemann, Adriano Aguzzi

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Divalent siRNA for prion disease.Nucleic acids research · 2026
    Article
  3. Article
  4. Divalent siRNA for prion disease.bioRxiv : the preprint server for biology · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. A New Take on Prion Protein Dynamics in Cellular Trafficking.International journal of molecular sciences · 2020
    Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Boris A BallmerInstitute of Neuropathology, University of Zurich, CH-8091 Zurich, Switzerland.
Rita MoosInstitute of Neuropathology, University of Zurich, CH-8091 Zurich, Switzerland.
Prisca LiberaliInstitute of Molecular Life Sciences, University of Zurich, CH-8091 Zurich, Switzerland; Friedrich Miescher Institute for Biomedical Research, 4058 Basel, Switzerland.
Lucas PelkmansInstitute of Molecular Life Sciences, University of Zurich, CH-8091 Zurich, Switzerland.
Simone HornemannInstitute of Neuropathology, University of Zurich, CH-8091 Zurich, Switzerland. Electronic address: simone.hornemann@usz.ch.
Adriano AguzziInstitute of Neuropathology, University of Zurich, CH-8091 Zurich, Switzerland. Electronic address: adriano.aguzzi@usz.ch.
University of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cellular prion protein, PrP

Indexed as

EndocytosisA549 CellsEndosomal Sorting Complexes Required for TransportFluorescence Resonance Energy TransferHeLa CellsHumansProtein TransportPrPC ProteinsPrPSc Proteinsrab5 GTP-Binding ProteinsReceptor, IGF Type 2Vesicular Transport Proteinscation-dependent mannose-6-phosphate receptorEHD1 protein, humanEndosomal Sorting Complexes Required for TransportPrPC ProteinsPrPSc ProteinsRAB5C protein, humanrab5 GTP-Binding ProteinsReceptor, IGF Type 2Vesicular Transport ProteinsVPS28 protein, humanVPS35 protein, humancell surfaceendocytosisfluorescence resonance energy transfer (FRET)high-throughput screening (HTS)prion disease

Identifiers

PMID28341739
PMCPMC5437241
OpenAlexW2603454659

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.